IntraBio Inc

2 in Phase 3

Quick facts

Phase 3 pipeline

IB1001 · Oncology
IB1001 is an intrabone injection therapy designed to deliver therapeutic agents directly into the bone marrow microenvironment.
N-Acetyl-L-Leucine · Neurology
N-Acetyl-L-Leucine enhances mitochondrial energy metabolism and reduces neuroinflammation to improve vestibular and cerebellar function.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: